XML 30 R21.htm IDEA: XBRL DOCUMENT v3.25.3
Earnings Per Common Share
9 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
Earnings Per Common Share

12. Earnings per Common Share

The following tables summarize the components of the basic and diluted EPS computations (in thousands, except per share amounts):

 

Three Months
Ended September 30,

 

 

Nine Months
Ended September 30,

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

EPS – basic:

 

 

 

 

 

 

 

 

 

 

 

 

Net income (numerator)

 

$

7,985

 

 

$

11,550

 

$

21,811

 

 

$

20,166

 

Weighted average common shares (denominator)

 

 

306,806

 

 

 

274,998

 

 

305,093

 

 

 

272,811

 

Net income per share

 

$

0.03

 

 

$

0.04

 

$

0.07

 

 

$

0.07

 

EPS – diluted:

 

 

 

 

 

 

 

 

 

 

 

 

Net income (numerator)

 

$

7,985

 

 

$

11,550

 

 

$

21,811

 

 

$

20,166

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares

 

 

306,806

 

 

 

274,998

 

 

 

305,093

 

 

 

272,811

 

Effect of dilutive securities – common shares issuable

 

 

4,832

 

 

 

9,695

 

 

8,246

 

 

 

8,596

 

Adjusted weighted average common shares (denominator)

 

 

311,638

 

 

 

284,693

 

 

313,339

 

 

 

281,407

 

Net income per share

 

$

0.03

 

 

$

0.04

 

$

0.07

 

 

$

0.07

 

For the three months ended September 30, 2025, diluted net income per share excluded the weighted average effect of 13.7 million shares of common stock underlying RSUs and Market and Performance RSUs, 0.8 million shares of common stock underlying options and PNQs and 7.0 million common shares issuable upon conversion of our senior convertible notes as they were antidilutive.

For the nine months ended September 30, 2025, diluted net income per share excluded the weighted average effect of 6.2 million shares of common stock underlying RSUs and Market and Performance RSUs, 0.3 million shares of common stock underlying options and PNQs and 7.0 million common shares issuable upon conversion of our senior convertible notes as they were antidilutive.

For the three months ended September 30, 2024, diluted net income per share excluded the weighted average effect of 10.4 million shares of common stock underlying RSUs and Market and Performance RSUs, 0.4 million shares of common stock underlying options and PNQs and 44.1 million common shares issuable upon conversion of our senior convertible notes as they were antidilutive.

For the nine months ended September 30, 2024, diluted net income per share excluded the weighted average effect of 9.1 million shares of common stock underlying RSUs and Market RSUs, 0.7 million shares of common stock underlying options and PNQs and 44.1 million common shares issuable upon conversion of our senior convertible notes as they were antidilutive.